Two Geeks + a Bench cover art

Two Geeks + a Bench

Two Geeks + a Bench

By: Annie + Diego
Listen for free

This Season's Biggest Deal | £0.99/mo for 3 months + £10 Audible bonus

£5.99/mo after 3 months - terms apply. Cancel monthly

Annie Graham is a Cosmetic Scientist and Co-Founder of Atomic Pom Labs. She formulates skincare, haircare and Body Care. Annie is an ingredient geek and texture whiz.

Dr. Diego Lapetina is a designer, digital genius and Co-Founder of Atomic Pom Labs. With a Post-Doctoral Fellowship in Psychiatry he has deep insight into branding and design. His focus is in the beauty niche where he designs for successful brands and founders.

© 2026 Two Geeks + a Bench Art
Episodes
  • Glossier: The Strategy Behind the Pink Pouch

    Glossier: The Strategy Behind the Pink Pouch
    Oct 30 2026
    What makes Glossier feel like Glossier? And how does a company hold on to that identity when it starts making more products, reaching more customers, and selling in new places?In this episode of Atomic Pom Labs, we use Glossier’s story to explore how brand strategy guides those decisions. We start with the familiar pink pouch, then follow the thinking that connects understanding an audience, developing products, earning trust, and choosing where to grow. The question running through the conversation is practical: how do you make the next business decision in a way that still makes sense to the customer?That question matters because growth brings options. A team can launch another version of an existing product, enter a different category, work with a new partner, or reach shoppers through another retailer. Each opportunity can come with a convincing business case. Customers, meanwhile, bring their own understanding of the company. A useful strategy helps the team consider both perspectives before an opportunity becomes a commitment.Glossier gives us a way to follow that process from an early stage. Before the company sold beauty products, Emily Weiss had launched Into The Gloss, where people shared routines, preferences, frustrations, and the products that had earned a place in their lives. Those conversations created an opportunity to hear how people actually experienced beauty. For anyone developing a business, that kind of listening can reveal needs that are difficult to see from inside a product meeting.We talk about why this understanding belongs early in product development. When marketing becomes a task to address after the product is finished, a team may have to search for an explanation that customers find relevant. Listening earlier gives the team more to work with. It can influence which problem to address, what to prioritize, how to describe the result, and where the product might fit into a customer’s routine. The customer’s language becomes useful throughout the process.From there, we look at “skin first, makeup second.” The phrase is memorable, but it also gives a team something to use. A developer considering two product directions can bring the discussion back to it. A writer can use it to decide which benefit deserves emphasis. Someone reviewing a campaign can ask whether the images support the same understanding. Positioning starts to earn its value when people can apply it to decisions that come up during an ordinary working day.That shared direction helps connect work happening across the business. The person developing a formula and the person writing a website may have different responsibilities, yet both contribute to the customer’s experience. When their choices fit together, the customer has a better chance of understanding the offer. Packaging, descriptions, demonstrations, and the product itself begin to give a consistent impression of what the company values and what someone can expect from buying it.We then follow that expectation into the purchase. Communication helps establish what the product should do; using the product gives the customer a chance to judge the promise. A satisfying experience provides a reason to consider buying again. Repeated experiences can make the choice feel more dependable. This connection between expectation and delivery helps explain why brand strategy needs to stay close to the actual experience of being a customer.As that trust develops, the company gains an opportunity to offer more. Existing customers may pay attention to a launch because a previous purchase worked well for them. That interest comes with an expectation, though. Customers have learned something about what the brand offers and where its strengths lie. A new product enters a relationship that already has some meaning. Understanding that relationship helps the team think through what an expansion will ask customers to believe.We spend time on the step between adding another version of a familiar product and introducing something different. Another shade gives a customer an additional choice within an experience they already understand. Entering a new category requires the company to explain another connection: why does this offer belong here? Working through that question can help a team evaluate the opportunity before the launch, while there is still room to reconsider the idea or make it clearer.Glossier You gives us a concrete example to discuss. We explore how a preference for an understated, skin-centered approach to makeup might connect with interest in a fragrance that feels personal and close to the skin. This is one way to understand the relationship between the fragrance and the broader brand idea. It also shows how a team might think beyond the category it currently serves while staying attentive to what customers already appreciate.The point of that example is to make the reasoning easier to examine. A brand name can attract attention to a new product, ...
    Show More Show Less
    9 mins
  • The Beauty Industry’s Prisoner’s Dilemma: Why Every Skincare Trend Rushes to the Shelf Before the Science Even Works

    The Beauty Industry’s Prisoner’s Dilemma: Why Every Skincare Trend Rushes to the Shelf Before the Science Even Works
    Sep 4 2026
    Exosomes went from a cellular biology term that nobody outside of advanced academic labs could pronounce to the frontline skincare shelves of Sephora in approximately eighteen months. That pace is startling, but it isn’t the story of scientific innovation hitting hyperdrive. It is the story of game theory playing out across the modern beauty market, where competitive incentives force corporate boardrooms into coordinated races to the bottom.To understand why the latest miracle serum arrives in your cabinet years ahead of verified clinical evidence, you have to look at the classic mathematical framework of the Prisoner’s Dilemma.Imagine two suspects arrested for a crime and locked in separate interrogation rooms. The prosecutor offers each the same calculated bargain. If both keep quiet, neither confesses, and both walk away with a minor infraction—a light sentence for mutual cooperation. If one talks first and implicates the partner, the informant walks out completely free while the silent partner takes the maximum sentence. But if both panic and betray each other at the same time, they both take the full hit.The tragic paradox of the dilemma is that talking is always the mathematically dominant move for the individual actor. Staying quiet relies on an impossible variable: absolute trust that the person in the other room will not sell you out to save themselves. When mutual trust is structurally impossible, defensive self-interest forces both parties to confess, producing an outcome objectively worse for everyone involved.Now take away the interrogation rooms and place two corporate beauty conglomerates at adjacent mahogany conference tables.Neither brand possesses conclusive human clinical trial data for the new wonder molecule. The biological mechanism behind exosomes is undeniably fascinating, but right now, it functions reliably only within controlled in vitro Petri dishes. Rigorous, double-blind, placebo-controlled human clinical trials—the kind required to determine bioavailability, penetration pathways, tissue longevity, and tangible anti-aging efficacy—remain years away.The research and development divisions at both companies know this reality inside and out. Their chief scientific officers sit across from executive leadership and say the exact same thing: the foundational science is not ready.Then Brand 1 looks at the media landscape, checks consumer search velocity, and chooses not to wait. They launch a premium anti-aging serum centered around the new buzzword, backed by speculative in vitro studies and aggressive marketing claims.At that exact second, the strategic question inside Brand 2 changes completely.Brand 2 is no longer evaluating whether the ingredient is dermatologically validated. That scientific question is instantly obsolete. Brand 2 is now calculating pure commercial survival: can they afford to be the only heritage beauty brand left behind when the cultural wave peaks?In contemporary cosmetic retail, product efficacy is rarely the primary existential risk. The true corporate nightmare is cultural obsolescence. Brands can survive minor reformulations, mixed product reviews, or quiet line discontinuations. What a prestige cosmetics line cannot survive is a front-page review from a leading beauty editor writing: "Every brand has answered the cellular longevity revolution—so why hasn't Brand 2 addressed exosomes?"The only rational counter-move left for Brand 2 is immediate concession: greenlight the launch, incorporate the ingredient, accelerate packaging runs, and claim their share of the conversation. Within weeks, Brand 3 joins the fray.Within a year and a half, mass-market contract manufacturers replicate the formula down to a stripped, ambient concentration, placing a derivative serum on drugstore shelves for $19.This is where the real commercial damage becomes visible: nobody actually wins the engagement.Every participating beauty house burns capital on high-velocity reformulations, rush-fee supply chains, expansive media-buying campaigns, and five-figure beauty influencer retainers. Yet when the dust settles, the collective theatrical blitz fails to create sustainable enterprise value. A miracle active cannot serve as an exclusive, defensible selling proposition when identical branding appears across twenty competitor SKUs in the exact same aisle. When an exotic raw material is suddenly everywhere, it permanently stops being special.Both cosmetic giants played the dominant strategy, and both surrendered the rarest asset in modern retail: clinical credibility.At the same time, consumers pay an invisible systemic cost as the baseline threshold of proof erodes across the industry. With every unchecked trend cycle, the minimum bar for what qualifies as acceptable evidence slips lower. In vitro Petri dish observations become good enough for consumer-facing claims. An unverified white paper authored by a wholesale raw ingredient supplier becomes good enough for a ...
    Show More Show Less
    4 mins
  • L’Oréal Doubled Down While You Panicked: The Counterintuitive Math of Winning in a "Soft" Market

    L’Oréal Doubled Down While You Panicked: The Counterintuitive Math of Winning in a "Soft" Market
    Aug 14 2026

    "The market is soft."

    If you work in beauty, wellness, or consumer goods, you’ve heard this phrase repeated like a corporate mantra all year. Boards are nervous, budgets are frozen, and leadership teams are slashing marketing expenditures to artificially protect short-term margins.

    There’s just one problem: someone forgot to tell L’Oréal.

    In the first half of 2026, while the rest of the industry braced for impact, L’Oréal posted nearly €24 billion in revenue, delivered 7% growth, and reported its highest operating margins in history.

    How did the biggest player in the game outperform everyone during a year deemed "weak"? The answer lies in a single, counterintuitive line item hidden inside their earnings report: they increased their marketing spending.

    In this episode, we break down why cutting marketing during a downturn is a fatal strategic mistake, the empirical math that proves spending during a slowdown creates disproportionate long-term value, and how you can apply these principles to capture market share right now.

    What We Cover in This Episode

    • The Reality of H1 2026: A look behind L’Oréal’s €24B performance and why their record-setting margins directly contradict standard corporate crisis playbooks.
    • The Math Behind Brand Growth (Binet & Field): Deconstructing decades of research on Excess Share of Voice (ESOV) and why your Share of Voice (SOV) must outpace your Share of Market (SOM) to generate actual expansion.
    • The "Discounted Attention" Phenomenon: What happens to advertising dynamics when competitors leave the table out of fear of board scrutiny.
    • The 10-to-0.5 Rule: How every 10 points of extra share of voice reliably yields half a percentage point of market share per year—and how compounding this over 3 to 5 years completely reorganizes category leadership.
    • Historical Precedents You Can’t Ignore:
      • The 2008 Financial Crisis: Why brands that stayed aggressive grew market share 4.5x faster during the recovery than those that pulled back.
      • The 1980s Recession: Why companies maintaining ad spend finished 256% ahead of their silent competitors.
      • The Great Depression (Kellogg’s vs. Post): The defining case study of Post cutting ad spend to protect profits while Kellogg’s doubled its investment—permanently seizing control of the cereal category for the next century.
    • The Strategic Fork in the Road: The two decisions facing every brand leader right now: retreat to protect margin percentages or stay at the table to buy long-term category equity.

    Key Takeaways & Frameworks

    1. Voice Is Not Noise—It’s Capital Investment

    When we talk about Share of Voice, we aren’t talking about vanity metrics or random posting. Voice represents structured, deliberate, and intentional communication across your ad spend, content channels, and brand narratives. If you hold 5% market share but command 15% share of voice, that 10-point gap is the literal engine of your future revenue.

    2. Why Soft Markets Make Advertising Cheaper

    In standard market conditions, the room is deafening. Every brand is spending heavily to shout over one another, diluting message resonance and driving acquisition costs up.

    In a downturn, fear takes over. Competitors quietly abandon the conversation, not because customer demand disappeared entirely, but because executive leadership is afraid of short-term quarterly variance. When they go silent, the room clears out. Your existing budget suddenly achieves 2x or 3x the relative visibility without you spending an extra dollar.

    3. The Asymmetry of Market Share Shifts

    Market share almost never shifts when times are booming; it shifts when markets slow down. The brands that stay consistent capture displaced customers, own top-of-mind recall, and emerge from the downturn with an insurmountable lead.

    Resources & Deep Dives

    Want to examine the raw data, calculations, and empirical research cited in this episode?

    • Full Editorial Analysis: Visit our website for the complete written report, charts, and financial breakdowns from this episode.
    • Daily Market Intelligence: Follow us on Instagram for daily coverage and strategic dissections of the business news actually driving modern brand performance.

    Enjoyed this episode? Subscribe, leave a 5-star review, and share this with a founder, marketer, or brand strategist who needs to hear the truth about navigating soft markets.

    Two Geeks at a Bench
    Show More Show Less
    5 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet